VP, Cardiology Clinical Development — Executive Ownership

Cornerstone Search Group; Philadelphia (Philadelphia County); On-site; USD 300,000 - 450,000; Full time

Job summary

Cornerstone Search Group is assisting a fast-growing clinical-stage biotech to appoint a VP, Clinical Development (Cardiology) to lead the cardiovascular program strategy, development plans, and regulatory shaping for a flagship asset.

You will work directly with the CEO, CMO, and senior leadership to influence portfolio decisions, build a high-performing clinical development team, and drive the program toward regulatory submission.

Qualifications

• Medical degree required; board certification strongly preferred.
• 12+ years of clinical drug development experience in pharma/biotech.
• Experience leading cardiovascular programs through late-stage trials.
• Strong understanding of trial design and regulatory strategy.
• Ability to influence cross-functional teams and senior leadership.

Responsibilities

• Serve as Clinical Lead with end-to-end ownership of the clinical strategy for a major program.
• Own development plans, protocols, indication selection, and target product profile development.
• Lead the Clinical Strategy Sub-Team and mentor physician scientists.
• Represent the company at scientific congresses, advisory boards, and regulatory meetings.
• Present strategy, progress, and risks to executive leadership and the Board.
• Build relationships with investigators and cardiovascular Key Opinion Leaders.

Skills

Clinical leadership

Cardiology

Regulatory strategy

Cross-functional leadership

Education

MD

Board certification

Fellowship in Cardiology

Job description

Cornerstone Search Group is assisting a fast-growing clinical-stage biotech to appoint a VP, Clinical Development (Cardiology) to lead the cardiovascular program strategy, development plans, and regulatory shaping for a flagship asset.

You will work directly with the CEO, CMO, and senior leadership to influence portfolio decisions, build a high-performing clinical development team, and drive the program toward regulatory submission.